Sickle cell experts say the future of a critical data collection program is in flux after staff at the CDC’s Division of Blood Disorders were placed on administrative leave without a clear future plan.

The study funding process came to a halt when the Trump administration announced on March 7 the cancellation of roughly $400 million in federal funds to Columbia University, through which funding flowed before it was sent to research sites across the country.

Indianapolis Zoo and Eli Lilly are part of a push to move medical industry away from using horseshoe crab blood and towards synthetic genetically engineered alternatives.

Experts believe the availability of life saving drugs may be responsible for the fall in overdose deaths

The attorneys general sent a letter saying the FDA needs to take action because high demand for the weight loss drugs paired with shortages has created a market for counterfeits.

A federal judge on Monday night temporarily stopped plans by the National Institutes of Health to cut funding to universities, hospitals and other research centers across the U.S.

If the Senate confirms Robert F. Kennedy Jr. — a vaccine skeptic — to lead the Department of Health and Human Services, he would control an influential group of federal vaccine advisors.

New research shows strong ties between alcohol and cancer, which has reignited a debate among experts about the health impacts of drinking, even in moderate amounts.

The USDA has outlined a five-point plan for regular bulk milk testing, which ramps up or down depending on whether any infected milk is detected.

More patients are coming to their doctors with questions about long held health practices. How should health experts respond?